WallStSmart

Innovative Eyewear Inc. (LUCY)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

West Pharmaceutical Services Inc generates 128389% more annual revenue ($3.07B vs $2.39M). WST leads profitability with a 16.1% profit margin vs 0.0%. WST earns a higher WallStSmart Score of 55/100 (C-).

LUCY

Hold

38

out of 100

Grade: F

Growth: 4.3Profit: 2.5Value: 5.0Quality: 5.0

WST

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for LUCY.

WSTSignificantly Overvalued (-256.8%)

Margin of Safety

-256.8%

Fair Value

$68.99

Current Price

$247.02

$178.03 premium

UndervaluedFair: $68.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LUCY2 strengths · Avg: 9.0/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Free Cash FlowQuality
$3.07B8/10

Generating 3.1B in free cash flow

WST2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

Areas to Watch

LUCY4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.6%4/10

1.6% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$5.89M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

WST3 concerns · Avg: 3.3/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

PEG RatioValuation
2.892/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : LUCY

The strongest argument for LUCY centers on Price/Book, Free Cash Flow.

Bull Case : WST

The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.

Bear Case : LUCY

The primary concerns for LUCY are Revenue Growth, EPS Growth, Market Cap.

Bear Case : WST

The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.

Key Dynamics to Monitor

LUCY profiles as a value stock while WST is a mature play — different risk/reward profiles.

LUCY carries more volatility with a beta of 3.23 — expect wider price swings.

WST is growing revenue faster at 7.5% — sustainability is the question.

LUCY generates stronger free cash flow (3.1B), providing more financial flexibility.

Bottom Line

WST scores higher overall (55/100 vs 38/100), backed by strong 16.1% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Innovative Eyewear Inc.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Innovative Eyewear Inc. (LUCY) is at the forefront of the smart eyewear market, combining cutting-edge technology with contemporary design to serve a tech-oriented consumer base. The company's flagship Lucyd product line integrates audio capabilities and seamless connectivity, offering practical functionality while maintaining fashionable appeal. With an unwavering commitment to innovation and user experience enhancement, LUCY is poised to capitalize on the expanding demand for multifunctional wearables, positioning itself for substantial growth in the dynamic eyewear industry.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?